• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Spontaneous remission of solar keratoses: the case for conservative management.

作者信息

Marks R, Foley P, Goodman G, Hage B H, Selwood T S

出版信息

Br J Dermatol. 1986 Dec;115(6):649-55. doi: 10.1111/j.1365-2133.1986.tb06644.x.

DOI:10.1111/j.1365-2133.1986.tb06644.x
PMID:3801305
Abstract

One thousand and forty people aged 40 years and over, 616 (59.2%) of whom had solar keratoses, were followed for 12 months. Two hundred and twenty-four people (36.4%) had a spontaneous remission of at least one of their solar keratoses. A total of 485 lesions (25.9%) underwent spontaneous remission out of the 1873 lesions that were present at the first examination of these 224 people. There was no significant difference between the number of lesions present at the initial examination in those who had a spontaneous remission compared with those who did not. There was a 21.8% increase in the total number of solar keratoses in the 1040 people studied in the 12-month period, due to new lesions forming at the same time as remissions were occurring. The incidence rate of squamous cell carcinoma occurring in the people with solar keratoses was 0.24% for each solar keratosis present at the original examination. With a substantial proportion of solar keratoses remitting spontaneously, plus the low rate of malignant transformation and the low potential for metastasis to occur from squamous cell carcinoma arising in a solar keratosis, the rationale of treating all solar keratoses appears questionable.

摘要

相似文献

1
Spontaneous remission of solar keratoses: the case for conservative management.
Br J Dermatol. 1986 Dec;115(6):649-55. doi: 10.1111/j.1365-2133.1986.tb06644.x.
2
Malignant transformation of solar keratoses to squamous cell carcinoma.日光性角化病向鳞状细胞癌的恶性转化。
Lancet. 1988 Apr 9;1(8589):795-7. doi: 10.1016/s0140-6736(88)91658-3.
3
High incidence and regression rates of solar keratoses in a queensland community.
J Invest Dermatol. 2000 Aug;115(2):273-7. doi: 10.1046/j.1523-1747.2000.00048.x.
4
Non-melanoma skin cancer and solar keratoses. I. Methods and descriptive results of the South Wales Skin Cancer Study.非黑色素瘤皮肤癌和日光性角化病。一、南威尔士皮肤癌研究的方法和描述性结果。
Br J Cancer. 1996 Oct;74(8):1302-7. doi: 10.1038/bjc.1996.534.
5
Managing solar keratoses.
Drug Ther Bull. 2002 May;40(5):33-5. doi: 10.1136/dtb.2002.40533.
6
Solar keratoses.日光性角化病
Br J Dermatol. 1990 Apr;122 Suppl 35:49-54. doi: 10.1111/j.1365-2133.1990.tb16125.x.
7
The relationship of basal cell carcinomas and squamous cell carcinomas to solar keratoses.基底细胞癌和鳞状细胞癌与日光性角化病的关系。
Arch Dermatol. 1988 Jul;124(7):1039-42.
8
The role of childhood exposure to sunlight in the development of solar keratoses and non-melanocytic skin cancer.儿童时期暴露于阳光下在日光性角化病和非黑素细胞性皮肤癌发生发展中的作用。
Med J Aust. 1990 Jan 15;152(2):62-6. doi: 10.5694/j.1326-5377.1990.tb124456.x.
9
Non-melanotic skin cancer and solar keratoses in Victoria.维多利亚州的非黑素瘤皮肤癌和日光性角化病。
Med J Aust. 1983;2(12):619-22. doi: 10.5694/j.1326-5377.1983.tb122724.x.
10
Epidemiology of non-melanoma skin cancer and solar keratoses in Australia: a tale of self-immolation in Elysian fields.澳大利亚非黑色素瘤皮肤癌和日光性角化病的流行病学:极乐世界中的自我毁灭故事。
Australas J Dermatol. 1997 Jun;38 Suppl 1:S26-9. doi: 10.1111/j.1440-0960.1997.tb01004.x.

引用本文的文献

1
mRNA expression of caspase 14 in skin epithelial malignancies.皮肤上皮性恶性肿瘤中半胱天冬酶14的mRNA表达
Postepy Dermatol Alergol. 2023 Apr;40(2):315-320. doi: 10.5114/ada.2023.127646. Epub 2023 May 31.
2
Severity of Local Skin Reactions with 4% 5-Fluorouracil Plus Emollient versus 4% 5-Fluorouracil Alone in Patients with Actinic Keratosis: A Single-Blind Randomised Trial.4% 5-氟尿嘧啶联合润肤剂与单用4% 5-氟尿嘧啶治疗光化性角化病患者的局部皮肤反应严重程度:一项单盲随机试验
Dermatol Ther (Heidelb). 2023 Apr;13(4):1013-1027. doi: 10.1007/s13555-023-00902-6. Epub 2023 Mar 1.
3
Profile of Tirbanibulin for the Treatment of Actinic Keratosis.
替拉瑞林治疗光化性角化病的概况
J Clin Aesthet Dermatol. 2022 Oct;15(10 Suppl 1):S3-S10.
4
Method of Assessing Skin Cancerization and Keratoses (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization.皮肤癌化和角化评估方法(MASCK™):一种用于评估广泛皮肤癌化患者的新型临床评估工具,在多个解剖部位的开发和摄影验证。
Clin Exp Dermatol. 2022 Jun;47(6):1144-1153. doi: 10.1111/ced.15136. Epub 2022 Mar 22.
5
Ingol and Ingenol-Type Diterpenes from Miller with Keratinocyte Inhibitory Activity.来自米勒的具有角质形成细胞抑制活性的英戈尔和大戟二萜醇型二萜类化合物。
Plants (Basel). 2021 Jun 14;10(6):1206. doi: 10.3390/plants10061206.
6
Guidelines of care for the management of actinic keratosis.光化性角化病治疗管理指南。
J Am Acad Dermatol. 2021 Oct;85(4):e209-e233. doi: 10.1016/j.jaad.2021.02.082. Epub 2021 Apr 2.
7
Murine Skin Carcinogenesis and the Role of Immune System Dysregulation in the Tumorigenicity of 2-Ethylhexyl Acrylate.小鼠皮肤癌发生以及免疫系统失调在丙烯酸2-乙基己酯致瘤性中的作用
Biomed Hub. 2020 Sep 2;5(2):958-973. doi: 10.1159/000508295. eCollection 2020 May-Aug.
8
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.光化性角化病、皮肤原位癌及局部治疗疗效的综述。
Australas J Dermatol. 2021 May;62(2):119-123. doi: 10.1111/ajd.13447. Epub 2020 Aug 25.
9
P53 staining index and zonal staining patterns in actinic keratoses.光化性角化病中 P53 染色指数和区域性染色模式。
Arch Dermatol Res. 2021 May;313(4):275-279. doi: 10.1007/s00403-020-02104-y. Epub 2020 Jul 8.
10
Actinic keratoses: review of clinical, dermoscopic, and therapeutic aspects.光化性角化病:临床、皮肤镜及治疗方面的综述
An Bras Dermatol. 2019 Nov-Dec;94(6):637-657. doi: 10.1016/j.abd.2019.10.004. Epub 2019 Nov 6.